1.
Sensory neuroimmune signaling opens a new precision medicine window for Stevens–Johnson syndrome and toxic epidermal necrolysis. Novera. 2026;1(1). Accessed April 22, 2026. https://submit.noverapress.com/index.php/Novera/article/view/10